CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.23B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.03: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.66%Below 5Y avg (0.98%)
Annual Rate
CNY 0.05Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jul 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.22BCNY1.23B · vs all stocks (USD)
Trailing P/E
58.31xRevenue (TTM)
5.85BCNY873.56M · vs all stocks (USD)
Profit Margin
2.46%Beta
0.2240xvs all stocks
52-Week Change
-20.37%vs all stocks
Forward Annual Dividend Yield
0.66%vs all stocks
Market Capitalization
8.22BCNY1.23B · vs all stocks (USD)
Enterprise Value
8.52BCNY1.27B · vs all stocks (USD)
Trailing P/E
58.31xForward P/E
13.07xPrice to Sales (TTM)
1.35xPrice to Book (MRQ)
1.53xEnterprise to Revenue
1.46xEnterprise to EBITDA
13.34xGross Margin
23.04%Profit Margin
2.46%Operating Margin
4.90%Return on Assets (TTM)
1.35%Return on Equity (TTM)
3.10%Revenue (TTM)
5.85BCNY873.56M · vs all stocks (USD)
Revenue per Share (TTM)
5.72CNYUpdated Sep 22, 2026Quarterly Revenue Growth
9.50%Gross Profit (TTM)
1.26BCNY187.73M · vs all stocks (USD)
EBITDA (TTM)
727.88MCNY108.69M · vs all stocks (USD)
Net Income (TTM)
143.62MCNY21.45M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
200.60%Operating Cash Flow (TTM)
744.64MCNY111.20M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
704.02MCNY105.13M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0500CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.66%vs all stocks
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.66%vs all stocks
5-Year Average Dividend Yield
0.98%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
141.98MCNYFY2025 · Dec 31, 2025Revenue
5.77BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.49BCNYFY2025 · Dec 31, 2025Gross Profit
1.27BCNYFY2025 · Dec 31, 2025Operating Income
274.72MCNY41.02M · vs all stocks (USD)
Pre-tax Income
161.21MCNYFY2025 · Dec 31, 2025Income Tax Expense
49.30MCNYFY2025 · Dec 31, 2025Net Income
111.91MCNYFY2025 · Dec 31, 2025EBIT
226.99MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
727.88MCNYFY2025 · Dec 31, 2025Research & Development
299.15MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
342.00MCNYFY2025 · Dec 31, 2025Other Operating Expenses
57.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
65.79MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
935.87MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
935.87MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
111.91MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
398.46KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
519.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
285.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.12BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
111.91MCNYFY2025 · Dec 31, 2025Other Non-cash Items
64.01MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
169.33MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
174.59MCNYFY2025 · Dec 31, 2025Capital Expenditures
-234.66MCNYFY2025 · Dec 31, 2025Sale of Investments
1.19MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-233.47MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.88BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.64BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-166.30MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.09BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
1.16BCNYFY2025 · Dec 31, 2025Shares Outstanding
1.05BSharesUpdated Sep 22, 2026Float Shares
818.23MSharesUpdated Sep 22, 2026% Held by Insiders
27.97%vs all stocks
% Held by Institutions
3.65%vs all stocks
Total Cash (MRQ)
1.88BCNY280.69M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.80CNYUpdated Sep 22, 2026Total Debt (MRQ)
2.33BCNY347.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4305xCurrent Ratio (MRQ)
1.61xBook Value per Share (MRQ)
4.96CNYUpdated Sep 22, 2026Total Assets
10.03BCNY1.50B · vs all stocks (USD)
Total Current Assets
4.95BCNYFY2025 · Dec 31, 2025Total Liabilities
4.78BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.08BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.38BCNYFY2025 · Dec 31, 2025Total Current Liabilities
3.40BCNYFY2025 · Dec 31, 2025Cash
2.12BCNYFY2025 · Dec 31, 2025Cash Equivalents
227.56MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.34BCNYFY2025 · Dec 31, 2025Accounts Receivable
748.51MCNYFY2025 · Dec 31, 2025Inventory
1.25BCNYFY2025 · Dec 31, 2025Accounts Payable
1.05BCNYFY2025 · Dec 31, 2025Short-term Debt
1.98BCNYFY2025 · Dec 31, 2025Other Current Liabilities
7.81MCNYFY2025 · Dec 31, 2025Long-term Debt
1.09BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.05BCNYFY2025 · Dec 31, 2025Retained Earnings
1.14BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.26BCNY784.97M · vs all stocks (USD)
52-Week Low
6.48CNYUpdated Sep 22, 202652-Week High
10.89CNYUpdated Sep 22, 202652-Week Change
-20.37%vs all stocks
Beta
0.2240xvs all stocks
50-Day MA
7.46CNYUpdated Sep 22, 2026200-Day MA
8.22CNYUpdated Sep 22, 2026Avg 10-Day Volume
20.21MSharesUpdated Sep 22, 2026Avg 30-Day Volume
27.51MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1300CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.03: grey zoneSignificant
Altman Z-Score: 2.03
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.23B, above the global median of $1.18BNotable
Market cap (USD): 1,226,774,569.841Global Median: 1,180,223,658.953
Revenue is $873.56M, above the global median of $548.88MNotable
Revenue (USD): 873,563,583.898Global Median: 548,883,780.48
Levered free cash flow is $105.13M, above the global median of $18.73MNotable
Levered free cash flow (USD): 105,131,206.25Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Cronos Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Carsgen Therapeutics Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Aurisco Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Harrow Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kissei Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai MicroPort EP MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Sun-Novo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Celltrion Pharm, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sonoscape Medical Corp.
Tier 1ProductionApproval-Gated PipelineRule
LB Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule